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 I get knocked down, but I get up again 
You’re never gonna keep me down 
                               Chumbawamba 

ABSTRACT 
The linker histone H1 and the androgen receptor are two different players in the chromatin 
orchestra. The linker histone H1, one of the most abundant proteins in the nucleus, is located at 
the surface of the nucleosome but despite many important functions reported for this protein it 
is not as well studied as the core histones. The androgen receptor, AR, is a member of the 
nuclear receptor family, a conserved family of transcription factors. AR is of uttermost 
importance for many functions in the human body as well as a driving force behind the most 
common cancer form in Sweden: prostate cancer. 
 
Paper I: Here we focus on the linker histone and the question of whether the heterogeneity of 
the linker histone family has a functional significance. By reconstituting individual H1 subtypes 
in Xenopus oocytes, a model system that lacks somatic linker histone, we have systematically 
studied their specific binding to chromatin and their effect on the chromatin structure as seen by 
increase in nucleosomal repeat length, NRL. We have compared linker histones that differ both 
in terms of origin and expression pattern as well as the ubiquitously expressed human somatic 
subtypes. We show that the biggest differences in terms of effect on chromatin structure are 
found between the coexisting human subtypes thus suggesting that H1 subtypes have different 
roles in the organization and function of the chromatin fiber. 
 
Paper II: Previous studies have shown that the binding abilities of H1 are at large determined 
by the properties of its C-terminal domain while much less attention has been paid to the role of 
the N-terminal domain. Using the same assay as in Paper I we compared the binding properties 
of wild type H1.4 and hH1.4 devoid of its N-terminal domain (ΔN-hH1.4). We showed that the 
lack of N-terminal domain does not have any effect on the hH1.4 induced increase in the NRL; 
however, the ΔN-hH1.4 displays a drastically lower affinity for chromatin binding as compared 
to the wt hH1.4 and is more prone to unspecific chromatin binding. We conclude that the N-
terminal domain of H1 is an important determinant of affinity and specificity of H1-chromatin 
interactions. 
 
Paper III: Prostate cancer growth is regulated by AR. Antiandrogens (AR antagonists) 
compete with androgens for binding to AR and are thus used to stall cancer cells. However, 
invariably patients develop resistance to such therapy and relapse with castration-resistant 
prostate cancer. This motivates the creation of a second generation of AR antagonists with a 
more clear-cut anti AR activity. By reconstitution of the hormone regulated mouse mammary 
tumor virus promoter, MMTV, in Xenopus oocytes we previously revealed that the 
transcription factor FoxA1 is able to convert the glucocorticoid antagonist RU-486 to a partial 
agonist by presetting of the chromatin structure at the hormone-responsive enhancer. High level 
of FoxA1 is a negative prognostic factor in prostate cancer and we decided to evaluate the 
effect of the AR antagonists bicalutamide (BIC) and MDV3100 (MDV) on transcriptional 
outcome of AR-dependent MMTV promoter in the context of FoxA1. Here we show that both 
antagonists, upon binding to AR, can translocate the AR-ligand complex to the nucleus, albeit 
with reduced efficiency for MDV. While in the nucleus both AR-antagonist complexes have the 
potential to bind sequence specifically to the hormone response elements, HREs, in vivo. The 
DNA binding is strongly enhanced by co-expression of FoxA1 that makes the HREs more 
accessible for AR binding. In this context BIC antiandrogenic ability is seriously compromised 
whereas MDV shows a more persistent antagonistic activity. We believe that these findings 
may be of clinical relevance. 
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1 INTRODUCTION 
 
 “DNA is just a tape carrying information, and a tape is no good without a player”.  
                                                                                             Bryan Turner, PhD, FMedSci 
 
“We are more than the sum of our genes. We are the sum of our gene expression” 
                                                              Per-Henrik Holmqvist, PhD (slightly modified). 
 
1.1 CHROMATIN –A SHORT INTRODUCTION 
 
Every cell in the human body contains 2 meter of DNA. In order to make it fit into the 
cell nucleus, that usually has a diameter of 5-10 µm, genomic DNA of all eukaryotes is 
organized in a complex structure together with proteins called chromatin (Kornberg, 
1974).  The packaging unit of chromatin is the nucleosome, consisting of 146 bp of 
DNA wrapped with 1.65 turns around an octamer of so called histone proteins, forming 
the nucleosome core particle (Luger et al, 1997). Another type of histone protein, the 
linker histone, often collectively also referred to as histone H1, is located at the surface 
of the nucleosome core particle contacting the interconnecting linker DNA. The 
chromosomal DNA in its most expanded form is organized in an 11 nm thick beads-on-
a-string structure, with nucleosomes forming the beads and the interconnecting DNA 
being the strings. However, this structure probably does not exist in vivo, but only in the 
test tube. In the cell, the nucleosomes are most probably folded into a higher order 
structure, the 30 nm fiber, a fiber that can be further compacted into 100-400 nm thick 
structures (Fig 1). 
 
 
 
Figure 1 The chromatin structure. The packaging unit of the chromatin structure, the 
nucleosomes (here displayed without linker histones) are arranged into a 30 nm thick fiber. 
This can in turn be packed to 100-400 nm thick structures (not shown).  
(Picture adapted from Kinner A et al. (2008) Nuc. Acids Res. 36(17)5678-5694) 
 
However, to make the DNA fit into the tiny space of the cell nucleus is not the only 
function of chromatin. Another just as important function is to control gene expression, 
i.e. to ensure that a particular gene is expressed in the correct cell, and at the correct 
time. The human body comprises of some 200 different cell types. Each cell contains 
the same DNA, i.e. carries the same genetic information. Yet, a liver cell differs 
profoundly from, for example, a skin cell or a cell in the eye. Likewise, monozygotic 
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twins carry identical genetic information and still sometimes don’t have identical 
phenotypes. Hence, what matters is not only if a certain gene is present or not but also 
its level of expression. 
How is the control over gene expression exerted? There are several ways, and to 
understand them we need to go down to the level of the packaging unit of the chromatin 
structure –the nucleosome. 
 
 
1.1.1  The nucleosome 
The protein octamer at the center of the nucleosome contains two copies each of the 
highly conserved histone proteins H2A, H2B, H3 and H4 (Kornberg & Thomas, 1974; 
McGhee & Felsenfeld, 1980). These proteins are small and they all share a common 
structure with a globular domain consisting of a long central helix flanked on either side 
by a loop and a shorter helix and an unstructured tail in the N-terminal domain 
(reviewed in (Ramakrishnan, 1997)). The crystal structure of nucleosome core particle 
was solved with high resolution (Luger et al, 1997). The N-terminal tails are protruding 
from the core of the nucleosome and subjected to covalent modifications such as 
acetylation, methylation, phosphorylation, etc. These modifications serve as signals for 
the activation or repression of gene expression, through the recruitment of different 
factors (reviewed in (Jenuwein & Allis, 2001)). Acetylation of the core histone tails 
generally leads to more open structures that are more prone to transcriptional activity. 
On the contrary methylation of certain residues, such as H3K9, leads to repression of 
transcription whereas methylation of others, such as H3K4 and H3K36, leads to 
activation.  
Thus the expression of information encoded in the DNA is in part regulated by the 
modifications of the histone tails (Strahl & Allis, 2000).  
 
 
1.1.2 Epigenetic mechanisms 
Epigenetics define the heritable, but reversible, changes in gene expression that are not 
encoded in the DNA sequence itself. Histone modifications is one example of 
epigenetic programming; methylation of DNA is another one. The methylation of CpG 
dinucleotides in the DNA exerts control of gene expression in two ways. First, the 
presence of a methyl groups can inhibit the binding of transcription factors that 
recognizes CpG sequences (Watt & Molloy, 1988). Second, the methylated DNA can 
attract proteins with a so called methyl-binding domain that in turn associate with co-
repressor complexes such as histone deacetylases and histone methyltransferases 
(reviewed in (Deaton & Bird, 2011)).  
 
Epigenetic regulation of gene expression constitutes the basis for the development of 
different cell types from the same genome. Epigenetic mechanisms are also responsible 
for the phenotypical differences between monozygotic twins, differences that tend to 
increase with age (Fraga et al, 2005a). 
In recent years, a lot of effort have been made not only to understand how the 
epigenetic regulation of the organism development but also to elucidate how epigenetic 
misregulations may cause disease(s) (reviewed in (Ballestar, 2011)). Results from some 
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studies have also indicated that epigenetic patterns can be inherited through generations 
(reviewed in (Peaston & Whitelaw, 2006)). For example, the access to food and 
nutrition in one generation was found to affect the health of the next; when a father 
experienced a poor availability of food during the period before the onset of puberty, his 
sons were found to be less prone to cardiovascular death (Kaati et al, 2002). However, 
the exact  mechanisms on the molecular level for this phenomenon remain unclear. 
 
 
1.1.3 Euchromatin and heterochromatin 
Traditionally chromatin has been divided into heterochromatin and euchromatin. These 
two forms were distinguished cytologically by how intensely they are stained. 
Euchromatin stains less intense and constitutes more open chromatin structure, while 
heterochromatin stains intensely and is characterized by a tightly packed chromatin 
structure, without much gene expression. Heterochromatin can in turn be subdivided 
into constitutive heterochromatin that remains silent throughout the life span of an 
organism and facultative heterochromatin which expression is developmentally 
regulated. Example of constitutive heterochromatin is the tightly packed structures next 
to the centromeres and in telomeres and examples of facultative chromatin are 
promoters of genes that are silenced during development (reviewed in (Craig, 2005)). 
 
 
1.2 THE “FORGOTTEN” COMPONENT OF CHROMATIN: THE LINKER 
HISTONE 
 
The X-ray crystal structure of the nucleosome core particle was resolved in 1997 
(Luger et al, 1997). However, one important piece of information was, and is still, 
missing; namely the location of the linker histone on the nucleosome. Here it should be 
pointed out that the linker histone family in mammals is big and heterogenous, 
consisting of several different isoforms. The linker histone is sometimes referred to as 
histone H1 and in this thesis the members of the linker histone family will often 
collectively be referred to as H1, even though some linker histone variants are known 
by other names.  
 
 
 
Figure 2 The structure of the metazoan linker histone. The linker histone has a three 
domain structure; a globular domain of ~60 aa, and two protruding tails that can be subjected 
to modification. The N-terminal domain is 20-40 aa long, while the C-terminal domain is ~100 
aa and rich in positively charged residues. 
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The metazoans H1 molecule has a three domains structure, with a globular domain, a 
short N-terminal domain and a long, basic C-terminal domain as shown in Fig. 2 (Allan 
et al, 1980; Bradbury et al, 1975; Chapman et al, 1976; Hartman et al, 1977). 
H1 is located close to the nucleosomal dyad and interacts with DNA where it enters and 
exits the nucleosome (Allan et al, 1980; Goytisolo et al, 1996; Zhou et al, 1998). This 
brings the segments of the linker DNA together to form a characteristic stem structure 
(Bednar et al, 1998) (Fig 3) which stabilizes the DNA wrapping and preventing 
unpeeling of DNA from the histone octamer. The nucleosome core particle protects 
around 147 bp from digestion with micrococcal nuclease, MNase, an enzyme that 
cleaves the linker DNA. The presence of a linker histone results in protection of 
additional ∼20 bp from MNase digestion. The nucleosome structure containing one 
molecule of H1 and 20 additional bp DNA protected from digestion is called the 
chromatosome.  
H1 has been shown to be necessary for correct mammalian development (Fan et al, 
2003) as well as been implicated in disease development (Duce et al, 2006; Kim et al, 
2008; Trojer et al, 2007). However, while discussing factors that influence chromatin 
structure and gene regulation the role of H1 is often ignored. As can be seen in Fig 1 in 
some figures of chromatin structure H1 is even omitted. While much effort has been 
placed on understanding the language of the modifications of the core histones less 
effort has been placed on elucidating the function of the modifications of H1 (Jenuwein 
& Allis, 2001). While the role of different core histone subtypes, such as the H2A 
variant H2A.X or the H3 variant H3.3 have been elucidated, the role of the different H1 
subtypes are not as well understood.  
 
                                      
Figure 3 Binding of H1 The linker histone is bound at the surface of the nucleosome. In the 
presence of H1 the two segments of the linker DNA become juxtaposed roughly 8 nm from the 
nucleosome center, and remain together for 3-5 nm before diverging, forming a “stem 
structure” (Bednar et al, 1998). The location of the H1 N-terminal domain is not known, and 
hence this part is not included in the picture. 
 
 Is it correct to call the linker histone a forgotten protein? 
Yes and no. YES, because compared to the amount of research that has been done in 
the core histones field much less attention has been paid to the role of H1. And NO, 
because to say that H1 is forgotten is of course in one way to belittle the research that 
has been performed around H1 and to underestimate the knowledge that has been 
accumulated.  The primary research aside, a lot of reviews have also been written, 
however as Woodcock et al point out in their review (Woodcock et al, 2006) the title of 
many of the reviews ends with a question mark. And maybe this says something about 
how limited our current knowledge about H1 and its role in chromatin structure and 
gene regulation is today. The aim of the studies presented in this thesis was to bring 
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clarity to some of the questions regarding the role of H1 and its role in chromatin 
structure. 
 
 
1.2.1 Linker histone structure  
As previously described (Fig. 2) the linker histones of multicellular eukaryotes exhibit 
a tripartite structure with a globular domain of ~60 aa flanked by a short protruding 
amino-terminal domain (N-terminal tail) of 20-40 aa and a longer, lysine rich carboxyl 
terminal tail (C-terminal tail). The structure of the globular domain has been solved by 
X-ray crystallography and shown to consist of a 3-helix “winged helix” fold containing 
a helix-turn helix motif (Ramakrishnan et al, 1993). The N-terminal domain consists of 
two distinct parts; the first part is rich in alanines and prolines while the second part, 
closest to the globular domain is enriched in lysines (Bohm & Mitchell, 1985). The 
positively charged domain has been shown to acquire an α-helical structure in 
trifluoroethanol (Vila et al, 2002), but otherwise its structure is not known. The C-
terminal domain comprises almost half of the length of the linker histone and has been 
implicated to be a major contributor to H1’s binding abilities (Hendzel et al, 2004). The 
C-terminal domain is an intrinsically disordered domain, that only adopt a structure 
upon DNA binding (reviewed in (Caterino & Hayes, 2011)) One conserved feature of 
all linker histone variants is the presence of serine/threonine kinase phosphorylation 
sites, S/TPXK motifs, distributed throughout the molecule. Several S/TPXK motifs are 
present in the C-terminal domain of H1 and take part in DNA binding and function in 
the compaction of DNA during mitosis ((Bharath et al, 2003), reviewed in (Caterino & 
Hayes, 2011)). 
 
 
1.2.2 H1 Family 
Among the five histone families the H1 family is the fastest evolving and the most 
diverse (Eirin-Lopez et al, 2005). While the evolutionary origin of the core histones can 
be traced to archaeas, there is no evidence for the presence of H1 genes (Kasinsky et al, 
2001). However in eubacteria several genes coding for basic proteins with similarity to 
the lysine rich C-terminal domain of metazoan linker histones have been found. Thus it 
seems like the origin of H1 like proteins can be traced back to eubacteria. The 
acquisition of the globular domain and the N-terminal tail occurred later in evolution 
(Kasinsky et al, 2001).  
Lower eukaryotes such as fungi and yeast only have one type of H1, whose structure 
differs from the three domains structure found in metazoans. Tetrahymena 
Thermophilia contains a protein that shares the size, solubility properties and lysine 
richness of metazoans H1 but lacks the globular domain (Gorovsky et al, 1974; Wolffe 
et al, 1997; Wu et al, 1994). Saccaromyces cerevisiae contain an H1 homologue Hho1p 
with two regions that are homologous to the globular domain of higher eukryotes. They 
are connected with a protein whose amino acid composition and sequence is similar to 
that of the C-terminal domain of H1 in higher order species (Landsman, 1996; Patterton 
et al, 1998). However, this non-canonical linker histone is present in very low amount, 
with 1 H1 molecule per 37 nucleosomes and knock down of Hho1p had no effect on 
the chromatin structure, viability or growth rate (Freidkin & Katcoff, 2001). In contrast 
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to this, metazoan cells usually have an H1-to-nucleosome content of 0.5-1 and they are 
required for proper chromatin function.  
 
Most higher eukaryotes contain several H1 subtypes. One of the exceptions to this rule 
is Drosophila melanogaster (Nagel & Grossbach, 2000), that only contains one H1 
subtype. In the African clawed frog Xenopus laevis there are six subtypes (Risley & 
Eckhardt, 1981; Shechter et al, 2009b) and in chicken there are seven (Coles et al, 
1987). While some subtypes are present in all analyzed cell types, others are specific 
for certain cell types and for certain stages in development. In Xenopus three subtypes 
are somatic and they are present in all cells of the body, one is specific for terminally 
differentiated cells and two are specific for oocytes and sperm cells respectively (Risley 
& Eckhardt, 1981; Shechter et al, 2009b). In the chicken, six subtypes are somatic 
whereas one, H5, is present only in the repressed chromatin of erythocytes (Coles et al, 
1987). The chicken erythrocyte is a terminally differentiated cell with very compact 
and inert chromatin with long NRL. There are indications that the chicken erythrocyte 
has a total of 1.3 molecules of linker histones per nucleosome; 0.4 chH1 and 0.9 chH5 
(Bates & Thomas, 1981; Morris, 1976).  
 
1.2.2.1 H1 in humans 
Humans have 11 different subtypes of linker histone, each one corresponds to a 
homologue in mice. There have been difficulties in finding a consensus regarding the 
nomenclature of the human H1 subtypes. A summary of different nomenclatures is 
shown in Table 1. In this thesis and our papers we are using the nomenclature proposed 
by Albig and coworkers (Albig et al, 1993).  
 
Table 1 Different nomenclatures used in the H1 field 
 
 
The 11 known human subtypes are H1, H1.1-H1.5, H10, H1oo, H1t, H1T2, HILS1 and 
H1x ((Izzo et al, 2008) and references therein). These subtypes can be subgrouped 
according to their temporal and spatial expression. H10 is expressed throughout the cell 
cycle, i.e. is replication independent, and is predominantly found in terminally 
differentiated cell. H1oo is specific for oocytes and the H1t and H1T2 variants are 
present during mouse spermatogenesis in male germ cells (Drabent et al, 1996; Izzo et 
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al, 2008; Tanaka et al, 2001). In both human and mouse there are five somatic 
replication dependent subtypes, hH1.1-hH1.5. While the expression of hH1.1 seem to 
be restricted to testes, thymus and spleen hH1.2, hH1.3, hH1.4 and hH1.5 has been 
found in most if not all somatic cell types with H1.2 and H1.4 being the predominant 
variants in most of the cell types studied (Franke et al, 1998a; Franke et al, 1998b; Izzo 
et al, 2008; Meergans et al, 1997). hH1.2 and hH1.4 have also been found to exist in 
two different sequence variants. H1.2 has an Ala17Val substitution in 6.8% of the 
Swedish population and H1.4 was found to have a Lys173Arg in Raji cells (Sarg et al, 
2005). Analysis of H1x distribution showed that it is expressed in all tissues examined 
(Yamamoto & Horikoshi, 1996), but otherwise very little is known about this subtype.  
 
 
1.2.3 H1 location in the chromatin fiber 
The exact location of the linker histone on the nucleosome has for long been 
controversial and during the years several different models have been proposed. The 
original model placed the linker histone symmetrically with the globular domain 
contacting the DNA at the place where it enters and exits the nucleosome and shielding 
10 bp of linker DNA at either side of the nucleosome (Allan et al, 1980). Quantitative 
DNaseI footprinting experiments supported this view (Staynov & Crane-Robinson, 
1988). However, other studies in late 80’s suggested an asymmetrical placement of the 
H1 molecule. An et al. (An et al, 1998) showed that deposition of H1 the on 
nucleosome core particles resulted in 20 bp protection of the DNA on one side of the 
core particle and none on the other. Careful analysis performed in the Alan Wolffe lab 
indicated that H1 binding to nucleosome reconstituted on Xenopus borealis 5S DNA 
resulted in protection of 5 bp on one side of the nucleosome and 15 on the other (Hayes 
& Wolffe, 1993). Further studies suggested the linker histone to be located 
asymmetrically inside the DNA gyres, with the globular domain placed 65 bp away 
from the dyad axis (Hayes et al, 1994; Pruss et al, 1996). A drawback with these studies 
is that they were all performed in vitro, with nucleosomes reconstituted on a particular 
DNA sequence. H1 is known to play a repressor role at the 5S gene (described in 
further detail below) and thus, what is true for H1 binding at the 5S gene sequence may 
not be applicable to H1 binding at other sequences. 
In a study by Zhou et al. the H5 globular domain was deposited on bulk chromatosomal 
DNA.  It was shown that helix III of the globular domain binds to in the major groove 
of the first helical turn of the chromatosomal DNA while another binding site at the 
opposite side of the H5 globular domain contacting DNA near the dyad axis, thereby 
forming a bridge between the linker DNA and the nucleosomal DNA (Zhou et al, 
1998).  
 
In a more recent study the linker histone chaperone NAP-1 was used for deposition of 
H1.5 on the 601 DNA sequence, and the placement of H1.5 was then determined by 
electron microscopy and hydroxyradical (*OH) footprinting. It was shown that the 
presence of H1 induced a 10 bp protection from *OH cleavage in the DNA in the 
center of the nucleosome (Syed et al, 2010), thus supporting a symmetrical positioning.  
However, since the 601 DNA sequence was developed to provide a high affinity for 
nucleosome binding and positioning (Lowary & Widom, 1998) and in that sense differs 
from natural DNA, the conditions for H1 binding in this study may not accurately 
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reflect the conditions for H1 binding in the cell. Furthermore, another possible 
explanation for the 10 bp protection is that H1 binds slightly asymmetrically, and with 
contact points on the DNA on one of the sides of the nucleosome as well as in the 
middle of the nucleosome. Since H1 in this scenario would alternatively bind to, and 
thereby protect, either one or another site in different nucleosomes but always contact 
the same part of the DNA in the middle, the latter segment is the only one to be 
consistently protected from *OH degradation.  
 
Fluorescence recovery after photobleaching, FRAP, is a widely used method to 
measure the mobility of a protein in the cell. The protein of interest is tagged with a 
fluorescent protein, such as GFP. The fluorescence in a certain area in the nucleus is 
destroyed by intense illumination followed by measurement of the speed of recovery of 
the signal, i.e. the time it takes before the molecule with destroyed fluorescence is 
replaced by another molecule. In this way one can measure how long a molecule 
remains bound to a target site. FRAP studies have shown that while a majority of H1 
molecules take part in chromatin interaction at any given time, the interaction with 
chromatin occurs in “stop-and-go” mode with H1 molecules being continuously 
exchanged on the target site and with an average time on DNA of 200-400 seconds 
(Lever et al, 2000; Misteli et al, 2000; Th'ng et al, 2005). This argues for that rather 
than a certain H1 molecule being continuously bound to a certain nucleosome the 
nucleosome fiber is surrounded by H1 molecules, that takes turn in binding. By 
studying how H1’s mobility is changed after point mutations in the globular domain 
and computer based modelling Brown et al. mapped two binding sites in the globular 
domain of H1. One site was suggested to interact with the major grove near the dyad 
axis and the other with the minor grove of the linker DNA (Brown et al, 2006). 
Interestingly, another study that employed computational docking indicated three 
binding sites in the globular domain, corresponding to three different binding modes 
(Fan & Roberts, 2006). One binding mode is consistent with the symmetrical model, 
where the linker histone contacts the dyad and both strands of linker DNA while the 
second binding mode is compatible with the model proposed by Zhou et al. (Zhou et al, 
1998) where H1 binds to form a bridge between the linker DNA and the nucleosomal 
DNA. The third binding mode is consistent with the model proposed by Hayes and 
Wolffe (Hayes et al, 1994) where H1 binds 64 bp away from the dyad axis. The authors 
propose that different conditions and experimental setups may favour a certain binding 
mode thus explaining the different results observed in the different studies (Fan & 
Roberts, 2006). 
 
Using H1 constructs that lack the C-terminal tail and/or with site directed mutagenesis 
in the binding sites of the globular domain in FRAP experiments H1 has been shown to 
bind to chromatin with intramolecular cooperativity. This model suggests that the H1 
C-terminal domain makes the initial contact with the linker DNA. This interaction 
positions H1 in a way that makes it possible for either of the binding domains in the 
globular domain to bind to its target DNA. A conformational change occurs that brings 
the target for H1’s other binding domain closer allowing both binding domains to bind 
(Stasevich et al, 2010). The intramolecular cooperativity is negatively affected by 
acetylation of the core histones (Raghuram et al, 2010). 
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1.2.4 H1 in the living cell  
For many years the well accepted dogma postulated that the H1-to-nucleosome ratio 
was 1:1. However, more recent studies have indicated that H1-to-nucleosome ratio 
varies between cell types, and in most cell types the ratio is between 0.5-0.9 (reviewed 
in (Woodcock et al, 2006)).  As described earlier, FRAP data has shown that H1 is a 
highly mobile protein, and that the molecules take turn in binding to the nucleosomes.  
Eukaryotic cells exhibit a wide range of nucleosome repeat lengths, NRL, that differ 
between cell types (reviewed in (Woodcock et al, 2006)). The presence of H1 
influences NRL. The reason is that more negative charge provided by the DNA 
phosphate backbone is needed to neutralize the positive charge provided by H1; 
resulting in an increase in the length of the internucleosomal spacer upon H1 binding to 
the chromatin ((Blank & Becker, 1995) reviewed in (Woodcock et al, 2006)). Thus, 
cells with a higher H1- to- nucleosome ratio tend to have a longer NRL, and a reduction 
in H1 content leads to shorter NRL (Fan et al, 2005; Hashimoto et al, 2010; Woodcock 
et al, 2006). Shorter NRL is a characteristic of active chromatin domains and rapidly 
growing cells, such as embryonic stem cells (Berkowitz & Riggs, 1981; Cavalli & 
Thoma, 1993; Compton et al, 1976; Gottschling et al, 1983). In contrast, mature cells, 
with more compact chromatin, tend to have longer NRL (Compton et al, 1976; Morris, 
1976; Perisic et al, 2010) 
 
The presence of H1 leads to more tightly packed chromatin structures (Routh et al, 
2008; Thoma et al, 1979) and thus one of the functions of H1 is to help packing the 
chromatin and to stabilize higher order chromatin structures. In accord with this, 
electron microscopy and biochemical studies showed that a 50% reduction in H1 
content in the living cell leads to more irregular and open chromatin structures 
compared to the wild type cells (Fan et al, 2005).  
  
 
1.2.5 Is there life without H1? 
The complete knock down of the non-canonical H1s in Tetrahymena Thermophilia 
(Shen et al, 1995) or Saccaromyces cerevisiae had no obvious phenotypic effects 
(Patterton et al, 1998) and the replacement of the hhoA gene encoding three canonical 
H1s in Aspergillus nidulans gave the same result (Ramon et al, 2000). Knock down of 
two H1 subtypes in mice resulted in viable mice with no apparent phenotype aside from 
compensatory upregulation of the genes coding for the other H1 subtypes (Fan et al, 
2001). However, when the somatic subtypes H1.2, H1.3 and H1.4 were knocked down 
simultaneously the embryos died latest at stage E11.5 displaying a wide range of 
developmental defects (Fan et al, 2003). Hence, a correct amount of linker histone is 
necessary for mammalian viability. A more recent study showed that knock down of 
the only H1 gene in Drosophila also results in lethality (Lu et al, 2009b). 
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1.2.6 H1 and transcription 
The exact role of H1 in transcriptional regulation is obscure. Due to its chromatin 
compaction abilities and the results from in vitro studies H1 was for many years 
believed to act as a global repressor (O'Neill et al, 1995; Shimamura et al, 1989).  
Although the 50% reduction of H1 level in mouse embryonic stem cells resulted in 
global changes in chromatin structure such as decompaction and decrease in NRL, very 
few changes in gene expression were observed:  only 29 genes showed a difference of 
2-fold or more, and of them 19 genes showed increased expression and 10 showed 
decreased expression (Fan et al, 2005). Thus, a reduction of H1 does not result in a 
global up or down regulation in gene expression but rather affects a subset of genes to 
different extent. This indicates that the role of H1 is neither that of a global repressor or 
activator, but rather that of a “lubricant” involved in fine-tuning of gene expression. 
 
1.2.6.1 H1 regulated genes  
There are though several examples of H1 involvement in the regulation of individual 
genes. The Xenopus somatic subtype xH1A starts to accumulate in the embryo during 
early gastrula (Dworkin-Rastl et al, 1994). At this time point it is involved in silencing 
of transcription from the 5S RNA gene (Bouvet et al, 1994; Kandolf, 1994) by 
positioning the nucleosomes in a way that inhibits transcription factor binding (Sera & 
Wolffe, 1998). 
Sometimes H1 exerts its effect on gene expression by the interaction with other factors. 
For example, the human subtype H1.5 forms a complex with transcription factor Msx1, 
binds to and induce chromatin repression at the key regulatory element of the gene 
coding for MyoD, a protein that controls skeletal muscle differentiation (Lee et al, 
2004). The human subtype H1.2 was found to be part of a complex that represses p53 
mediated transcription by blocking p300-induced acetylation of chromatin at the 
promoter region. (Kim et al, 2008). H1.2 has also been shown to be recruited by the 
chromatin remodeling complex CHD8 to suppress the wnt-β-catening-signalling 
pathway (Nishiyama et al, 2012).   
 
 
1.2.7 Posttranslational modifications of histone H1 
Just like the core histones, H1 is subjected to post-translational modifications. 
Masspectrometry studies of the modification pattern of H1 showed that the human and 
mouse H1 subtypes were subjected to phosphorylation, acetylation, methylation and 
ubitqutination on a number of different residues (Wisniewski et al, 2007). While some 
modifications were common to all H1 subtypes others were subtype specific. The 
modification pattern also differed between tissues taken from mice on one hand and 
MCF7 and HeLa cell on the other. Below the most well studied H1 modifications will 
be introduced. 
 
1.2.7.1 Phosphorylation  
The most extensively studied posttranslational modification of H1 is phosphorylation. 
Phosphorylation of H1 progressively increases during the cell cycle, reaches a maximal 
level in mitosis and then decreases rapidly in telophase (reviewed in (Happel & 
Doenecke, 2009)). A study of interphase phosphorylation pattern in T cells and Jurkat 
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cells has shown that phosphorylation starts in the second part of G1 phase and increases 
in the S phase (Green et al, 2011). Phosphorylation occurs either at the conserved 
cyclin-dependent kinase 1, CDK 1, S/TPXK motifs or at other sites that are not 
recognized by CDK1. Examples of the latter are hH1.4S2, hH1.4T4 and H1.4S27 
(Garcia et al, 2004). Phosphorylation during interphase was found to occur at serines in 
a subtype specific manner. H1.2 is phosphorylated on S172, hH1.3 on S188, H1.4 on 
S171 and S186 and hH1.5 on S17, S172 and S188 (Sarg et al, 2006). During mitosis 
hH1.5 is phosphorylated also at T137 and T154, and additional phosphorylation of the 
other subtypes most probably occurs as well (Sarg et al, 2006; Talasz et al, 2009). 
H1 phosphorylation was originally linked to the mitotic condensation of chromatin 
(Bradbury et al, 1974), but this view was later changed since chromatin condensation 
has been shown to occur without H1 in vitro ((Happel & Doenecke, 2009) and 
references therein). The view that H1 phosphorylation is not involved in condensation 
was in turn challenged when immunodepletion of H1 from Xenopus laevis egg extracts 
resulted in 50% elongation of the replicated chromosomes and failed alignment at the 
metaphase plate (Maresca et al, 2005). Furthermore, inhibition of H1 phosphorylation 
in FM3A cells resulted in a decline in mitotic cells and decondensation of the 
metaphase chromosomes (Th'ng et al, 1994). Exactly how phosphorylation of H1 is 
involved in chromatin condensation is unclear but a model has been proposed that the 
weakened H1-DNA interactions lead to a positioning of H1 that favors H1-H1 
interactions. These interactions may in turn take part in the formation of higher order 
chromatin structure (reviewed in (Roth & Allis, 1992)).  
 
H1 phosphorylation has also been linked to the decondensation of chromatin (reviewed 
in (Roth & Allis, 1992)). Local chromatin decondensation during S-phase correlates 
with the presence of phosphorylated H1, probably in a CDK-2 dependent manner 
(Alexandrow & Hamlin, 2005; Herrera et al, 1996). Phosphorylation is thought to exert 
its effect by the provision of negative charge that results in the repulsion of the H1 tails 
from the DNA thus weakening association with DNA (reviewed in (Happel & 
Doenecke, 2009)  and in (Roth & Allis, 1992)). Due to loss of the positive charge the 
negatively charged DNA strands will repel each other thus forming a less condensed 
chromatin structure. This view is supported by the FRAP analyses of H1 mutated to 
mimic dephosphorylated or phosphorylated H1 and FRAP studies performed in cells 
treated with kinase inhibitors. The results from these studies show that phosphorylated 
H1 exhibits increased mobility compared to the non-modified counterpart and argues 
for that phosphorylation is likely to affect H1 chromatin binding in a variant-specific 
fashion (Hendzel et al, 2004; Lever et al, 2000).  
 
A few studies found a potential link between H1 dephosphorylation and apoptosis (Guo 
et al, 2000; Kratzmeier et al, 2000). However later it was shown that dephosphorylation 
is rather caused by cell cycle arrest (Happel et al, 2005) and yet another study argued 
that H1 dephosphorylation is dependent on the method used to induce apoptosis and, 
thus, is no general hallmark of early apotosis (Green et al, 2008). 
 
There are data indicating that H1 phosphorylation can also be increased at the sites of 
active transcription and site-specific interphase H1 phosphorylation facilitates 
transcription by RNA polymerases I and II (Zheng et al, 2010). 
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Studies of the mouse mammary tumor virus, MMTV, promoter have shown that 
phosphorylation of H1 is required but not sufficient for glucocorticoid-dependent 
transcription from this promoter (Bhattacharjee et al, 2001; Lee & Archer, 1998). 
Binding of the progesterone receptor, that activates the MMMV promoter, increases the 
level of phosphorylated H1 present at MMTV minichromosomes reconstituted in HeLa 
cell extracts. (Koop et al, 2003). 
 
1.2.7.2 Methylation 
The human linker histone subtype hH1.4 is methylated on lysine 26 by the Polycomb 
repressor complex 2 (Kuzmichev et al, 2004) and methyltransferase G9a (Trojer et al, 
2009). This methylation site is recognized and bound by heterochromatin protein 1, 
indicating a role of this modification in the formation of heterochromatin. Interestingly, 
phosphorylation of the neighboring hH1.4S27 prevents HP1 from binding (Daujat et al, 
2005). The phosphorylation of S27 is cell cycle dependent and peaks in metaphase 
(Hergeth et al, 2011).  
The methyltransferase G9a also methylates lysines in the C-terminal domains of H1.2, 
H1.3, H1.5 and H1o. H1.2 is methylated on K187, a modification that is specific to 
H1.2. It is cell cycle independent and is not associated with HP1 (Weiss et al, 2010). 
 
1.2.7.3 Acetylation 
The human subtype hH1.4 may also be acetylated on residues K26 and K34 
(Kamieniarz et al, 2012). The K34 modification is enriched at transcription start sites 
and has been proposed to facilitate transcription by the “opening up” of chromatin and 
by assisting in the recruitment of transcription factors. The acetylation of K34 also 
increases the mobility of H1.4 as monitored by FRAP. Aside from the H1.4K34ac 
modification, acetylation of H1 is not well studied. 
 
1.2.7.4 Ubiqutination 
Ubiqutination has been found in H1.2, H1.3 and H1.4 at K46 from HeLa cells. It was, 
however, missing in the same H1 subtypes from MCF7 cells. Ubiqutination was also 
found in H1.1 at K116 from mouse tissue (Wisniewski et al, 2007). The functional 
significance of these modifications in H1 has yet to be elucidated, however, 
ubiquitinylation of core histones is most often associated with increased gene 
expression.  
 
 
1.2.8  Other roles for H1  
This thesis, as well as most other studies made on H1, is focused on the effect of H1 
subtypes on chromatin structure and gene regulation. However, another reason for 
having several H1 subtypes could be that they have different functions during mitosis 
and/or as signaling molecules. 
 
1.2.8.1 Role in mitosis 
A study of the distribution of the human subtypes H1.2, H1.3 and H1.5 showed 
different localization pattern during mitosis (Green et al, 2010). While hH1.3 was 
detected on chromatin during all cell cycle phases, with only small quantities present in 
the cytoplasm during late anaphase, hH1.2 was found interacting with chromatin during 
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interphase and prohpase but located exclusively in cytoplasm during 
prometaphase/metaphase. In late anaphase/early telophase hH1.2 was relocated to 
chromatin. hH1.5 largely followed the pattern of hH1.2 but was found both in 
cytoplasm and on chromatin during prometaphase/metaphase (Green et al, 2010). 
These differences in distribution indicate different roles of the H1 subtypes in mitosis. 
The dissociation of hH1.2 and hH1.5 from chromatin during mitosis can be explained 
by mitosis specific phosphorylation that decreases affinity for chromatin binding. 
However, both hH1.2 and hH1.3 contain four phosphorylation sites, of which three are 
in the C-terminal domain while hH1.5 contains five phosphorylation sites of which four 
are located in the C-terminal domain. hH1.2, hH1.3 and hH1.5 all contain two TPKK 
phosphorylation sites in the C-terminal domain. Hence, in terms of total number of 
phosphorylation sites H1.2 is similar to H1.3 while it behaves more like H1.5. Thus, 
one can speculate if these differences in behaviour are, at least partly, due differences 
between the H1.2 and H1.5 that are not coupled to modification status, such as inherent 
differences in chromatin binding affinity.  
 
1.2.8.2 Signalling molecule 
As was mentioned above, H1.2 is part of a complex that represses p53 mediated 
transcription (Kim et al, 2008). It was shown that hH1.2 is involved in apoptosis 
signalling induced by DNA double strand breaks. After exposure to X-ray irradiation, 
all H1 isoforms are released into the cytoplasm in a p53 dependent manner but only 
H1.2 could induce cytochrome c release from mitochondria and thereby trigger 
apoptosis (Konishi et al, 2003), thus, indicating that hH1.2 plays a role of a signalling 
molecule. 
 
1.2.8.3 H1 involvement in the functioning of the immune system 
A few reports suggest that H1 can be involved in the functioning of the immune 
system. The H1 subtype HIS-24 in C.Elegans has been shown to be a regulator of 
genes involved in antimicrobial defense; the level of monomethylated HIS-24K14 in 
the cell rises after bacterial infection. This modification is bound by the HP1-like 
protein HPL-1 on promoters involved in antimicrobial response (Studencka et al, 
2012).  
The forkhead transcription factor FoxP3 controls the development and is necessary for 
the function of the cells required for the maintenance of self-tolerance, the regulatory 
T-cells. FoxP3 exerts its function by binding to and mediating repression of the IL-2 
promoter. Linker histone subtype hH1.5 was shown to interact with FoxP3 in human T 
cells and co-expression of FoxP3 and hH1.5 lead to synergistic repression of the IL-2 
promoter. Knock down of hH1.5 inhibited the ability of FoxP3 to suppress IL-2 
expression, indicating a role for at least hH1.5 in the human immune system (Mackey-
Cushman et al, 2011). Subtypes H1.1-H1.5 exhibit antimicrobial activity against S. 
typimurium when extracted from terminal ileal mucosal cells. When 
immunohistochemical analysis was performed on tissue sections with a monoclonal 
antibody to H1 immunoreactive linker histone was shown to be present in the nuclei of 
epithelial cells as well as in the cytoplasm of some villus epithelial cell. Collectively 
these findings may indicate a role for H1 in the human innate immune system (Rose et 
al, 1998). 
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1.2.9 Potential role in disease development 
 
1.2.9.1 Cancer  
In recent years it has become clear that changes in the pattern of covalent core histone 
modifications are not only associated with certain types of cancer but also predictive of 
outcome (Fraga et al, 2005b; Schneider et al, 2011; Seligson et al, 2005). The role of 
linker histone H1 and its modifications, though, tends to be ignored. Even so, some 
results suggest that H1 not only plays important roles in the development of a healthy 
organism but also in the development of diseases. 
As discussed above the human linker histone subtype hH1.4 can be methylated on 
lysine 26 by the methyltransferase G9a (Trojer et al, 2009). This modification has been 
shown to interact with both the malignant brain tumor protein L3MBTL1 (Trojer et al, 
2007) and with heterochromatin protein 1. Mutations of the l3mbt gene in Drosophila 
causes brain tumors, and the L3MBTL1 protein in human is a transcriptional repressor 
(Boccuni et al, 2003). Loss of HP1 causes chromosome segregation defects, HP1 has 
also been shown to play a prominent role in the progression of many cancer types 
(reviewed in (Dialynas et al, 2008)).  
 
1.2.9.2 Alzheimers’disease 
Alzheimers disease is one of the most common forms of neurogenerative diseases. One 
of the characteristics of the disease is the accumulation of senile plaques in the brain 
(Tiraboschi et al, 2004). The major component of senile plaques is the amyloid-β-
protein (Aβ), a protein that under normal conditions is soluble but in the diseased brains 
aggregates into insoluble so called amyloid-like structures (Makin & Serpell, 2005). 
Duce et al. showed that the H1 subtypes H1.1-H1.5 are present in the amyloid plaques 
in mice model for Alzheiemers disease and that H1 shows increased binding to the 
amyloid-like forms of the Aβ-peptide in these mice (Duce et al, 2006). Disruption of 
this interaction in vitro required the presence of NaCl concentrations higher than 1M 
and thus cannot be explained just by electrostatic interactions (Duce et al, 2006). No 
differences were shown in the total H1 expression level in the brain of affected and 
control mice, however, in affected mice H1 tended to be localized to the cytoplasm of 
both neurons and astrocytic-like cells. It was speculated that both the release of H1 and 
its translocation into the cytoplasm as well as H1’s interaction with the amyloid-like 
motifs might trigger disease development. 
Aberrant interaction between H1 and amyloid-like fibrils may also be related to other 
neurodegenerative diseases such as Parkinson’s and Creutzfeldt-Jakob disease. 
 
 
1.2.10 The H1 family: Why so many different subtypes? 
Linker histones serve very important functions in chromatin structure and development. 
However, there are still a lot of unanswered questions and uncertainties around this 
protein. One such question is whether the heterogeneity of the H1 family is functionally 
important. 
 
The different subtypes of H1 are far more conserved between species than within them. 
Fig. 4 shows an alignment of the somatic human subtypes as well as the differentiation  
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Figure 4 (A) Alignment of the somatic human H1 subtypes and the differentiation specific H10. 
(B) Human H1.2, H1.3 and H1.4 aligned to their homologue in mouse. 
 
specific subtype H1o. The amino acid sequence of the globular domain is relatively 
conserved both between different subtypes from the same species, and also between 
species. The N-and C-terminal domains are more divergent between subtypes, however 
there is a high degree of sequence conservations between subtypes from different 
species. The mouse somatic subtypes H1.2, H1.3 and H1.4 are aligned to the human 
homologues in Fig 4B, and as can be seen they differ at around 25 residues. Since the 
C-terminal comprises about half of the protein, much of the diversity of the H1 family 
can be attributed to that part. 
But does this heterogeneity have any functional significance? Or is it only an artifact of 
evolution? The fact that the different subtypes are very conserved between different 
species strongly argues for distinct roles played different subtypes. However, knock 
down of differentiation specific subtype H10 in mice has no effect on the phenotype 
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(Sirotkin et al, 1995). The bulk H1/nucleosome ratio remained the same since the loss 
of H10 was compensated for by elevated expression of the somatic subtypes H1.2, H1.3 
and H1.4. A knock down of either one of H1.2, H1.3 and H1.4 alone or in combination 
with H10 did essentially show the same result –i.e. no visible phenotypic effects except 
upregulation of the remaining H1 subtypes (Fan et al, 2001). These results show that 
the somatic subtypes are able to replace each other to a certain extent and may argue for 
that the heterogeneity of the H1 family is not functionally important and rather is an 
evolutionary reminiscence. 
 
However, other studies led to different results. For example, a more careful analysis of 
the knock down mice showed that knock down of different H1 subtypes had different 
effects on the age dependent silencing of a transgene (Alami et al, 2003), different 
subtypes were shown to bind to chromatin with different affinity and localize to 
different parts of the chromatins structure in the living cell (Th'ng et al, 2005), the level 
of different subtypes has been shown to differ before and after T-cell activation (Green 
et al, 2011) and there are indications that different subtypes associate with different 
regulatory proteins (Kim et al, 2008; Lee et al, 2004). 
 
Thus, the question of whether this heterogeneity has any function to fill remain 
unanswered. And if yes, what is then the role of each different subtypes? 
 
 
1.3 NUCLEAR HORMONE RECEPTORS 
 
The members of the nuclear receptor (NR) family are examples of another type of 
players in the chromatin orchestra. Nuclear receptors are a conserved family of 
transcription factors with more than 300 recognized members that are known to play 
crucial roles in reproduction, development, metabolism, homeostasis and other 
processes (reviewed in (Whitfield et al, 1999)). Nuclear receptors are subdivided into 
different types (reviewed in (Tsai & O'Malley, 1994)). The type I receptors are also 
called the steroid receptors, since they are dependent on the binding of steroid 
hormones for their activation. Examples of this type of receptor are androgen receptor, 
estrogen receptor, glucocorticoid receptor, progesterone receptor and mineralcorticoid 
receptor. In the absence of ligand the steroid receptors resides in the cytoplasm where 
they are bound to heat shock proteins. However, upon ligand binding steroid receptors 
undergo conformational changes and translocate to the nucleus where they recognize 
and bind to response elements, so called hormone response elements, HREs, at the 
promoter of their target genes. In the case of type I NR, the HREs are made up of 
inverted repeats of DNA separated by a few bases. The second class of NRs, type II, 
includes the thyroid hormone receptor, vitamin D, retinoic acid and 9-cis retinoic acid 
receptors. This type of nuclear receptor binds DNA even in the absence of ligand and 
their HREs are made up of direct repeats. Type III nuclear receptors are also called 
orphan receptors, due to the fact that their ligand is not yet known or a ligand binding 
pocket may be missing. This is the biggest class of nuclear receptors (Kumar & 
Thompson, 1999; McKenna et al, 1999; Tsai & O'Malley, 1994). 
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1.3.1 Structure of nuclear receptors 
Nuclear receptors share a common structure with four main regions; an N-terminal 
trans-activating domain (NTD), a DNA-binding domain (DBD), a ligand binding 
domain (LBD) and a hinge region that connects the DNA-binding domain with the 
ligand-binding domain, see Fig. 5. 
 
 
Figure 5 The common structure for nuclear receptors: An N-terminal domain (NTD), a 
DNA-binding domain (DBD), a ligand binding domain (LBD) and a hinge region (Hinge) that 
connects the DNA-binding domain with the ligand binding domain.  
 
The least conserved part of NRs is the N-terminal domain containing a transcriptional 
activating domain called activation function 1 (AF-1) that can act in a ligand 
independent manner when separated from the receptor (Germain et al, 2006; Kumar & 
Thompson, 1999; Warnmark et al, 2003). The DNA-binding domain (DBD) is the most 
conserved domain. It consists of two zinc finger motifs that each contains four cysteine 
residues and forms a tertiary structure that interacts with the DNA at the HREs (Kumar 
& Thompson, 1999). The ligand domain is less conserved than the DBD in terms of 
sequence, however among the LBDs that have been solved by different means a 
common structure has been identified (Germain et al, 2006; Kumar & Thompson, 
1999; Warnmark et al, 2003). 
 
Steroid hormone or receptor agonist is a compound that binds the receptor and activates 
a biological response. A nuclear receptor antagonist is a substrate that can bind to the 
receptor but does not provoke the normal biological response and, thus, acts as a 
competitive inhibitor of receptor function. One example of a widely used 
glucocortiocid and progesterone receptor antagonist is RU486 that binds to and blocks 
the action of the progesterone as well as the glucocorticoid receptor. Progesterone is 
necessary to sustain a pregnancy, and RU486 is therefore used as an abortion pill (Fiala 
& Gemzel-Danielsson, 2006).  
 
1.4 ANDROGEN RECEPTOR  
 
Unlike the linker histone, the steroid receptor androgen receptor (AR), is far from being 
forgotten or underestimated. While a search at Pubmed for “linker histone H1” yielded 
∼1000 hits, a search for “androgen receptor” gave ∼18250 hits (May 2012). 
 
Just like linker histones, the androgen receptor is necessary for correct mammalian 
development and, as can be understood from its name, it is especially important for 
male sexual development. During the eighth to ninth weeks of gestation of a normal 
genetic male, the so called Leydig cells appear in the observable testis (Chemes, 2001). 
The Leydig cells secret testosterone that is converted by the enzyme 5α-reductase to 
5α-dihydrotestosterone, DHT - an even more potent androgen. Both testosterone and 
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DHT bind to and activate the androgen receptor which is necessary for the development 
of the male reproductive organs; prostate, testis and growth of the penis during embryo 
stages as well for the development of secondary sex characteristics later in life; muscle 
mass, hair and beard growth (reviewed in (Haendler & Cleve, 2012; Hughes et al, 
2001)). 
 
AR also contributes to several aspects of development of the central nervous system 
and to maintenance of its proper function in adulthood (reviewed in (Li & Al-Azzawi, 
2009)). In aging men, the levels of testosterone in the brain decreases, something that is 
thought to give consequences for the brain function and has been implicated to be a risk 
factor for Alzheimers disease (Rosario et al, 2004). Androgens also affect bone 
formation. The AR is expressed in osteoblasts (cells that are responsible for bone 
formation), osteocytes (cells found in the mature bone) and osteoclasts (cells that 
control the amount of bone tissue). Androgens stimulate the longitudinal growth in boys 
during puberty and after the cessation of bone growth, both the AR and the estrogen 
receptors are responsible for the maintenance of skeletal integrity (reviewed in 
(Carnevale et al, 2010)). Androgens directly stimulate the proliferation of osteoblast 
precursor via the Wnt signaling pathway (Liu et al, 2007), but also indirectly by 
increasing vitamin D synthesis that enhance intestinal calcium absorption (reviewed in 
(Foradori et al, 2008; Hagenfeldt et al, 1989).  
 
Except for its role as transcription factor, the AR has been shown to take part in non-
genomic signaling. It has been shown to rapidly modulate ion channels and increase the 
intracellular level of Ca2+ in a variety of cell types by a variety of non-genomic 
mechanisms. The AR has also been shown to activate other second messenger 
pathways, for example, it has been shown to stimulate Raf-1 and ERK-2, members of 
the MAPK signaling pathway as well as activate cAMP and protein kinase A, PKA and 
it also directly interacts with and stimulates signaling cascades (reviewed in (Bennett et 
al, 2010; Foradori et al, 2008)). 
 
 
1.4.1 AR gene 
The gene encoding the AR is located on the X chromsome (q11-12) and encodes a 
cDNA of roughly 2760 nucleotides. The human AR protein consists of approximately 
920 aa; residues 1-558 constitute the N-terminal domain, residues 559-624 constitute 
the DBD and 625- 676 constitute the Hinge-domain and 677-920 constitute the LBD 
(Bennett et al, 2010). However, the exact length of the protein may vary, due to 
variations in length of a poly-glutamine (poly-Q) and a poly-glycine (poly-G) tract in 
the N-terminal domain. 
The normal poly-Q repeat length is usually said to be some 10-35 residues (Bennett et 
al, 2010; Itkonen & Mills, 2011), One study found the mean repeat length among 75 
healthy patients to be 21±2, with a range of 17 to 26 residues (La Spada et al, 1991). 
Expansion of the repeats over 35 residues is associated with a decrease in AR 
transactivating function (Chamberlain et al, 1994). An extension of the repeat to 40-62 
residues is the cause behind the neuromuscular degenerative disease spinal and bulbar 
muscular atrophy (SBMA), or Kennedy’s disease (La Spada et al, 1991). This extension 
is thought to cause AR to aggregate inside motor neurons and induce neuronal cell 
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apoptosis, leading to gradual development of neurodegenerative disorders (Finsterer, 
2009). The longer the repeat length the earlier the onset and severance of the disease 
(Igarashi et al, 1992)However, also shorter repeat lengths have been associated with 
disease development and problems. For example ≤ 19 repeats has been associated with 
benign enlargement of the prostate defective,  ≥ 28 repeats spermatogenesis and ≤ 18 
repeats with prostate cancer (reviewed in (Bennett et al, 2010)). 
 
Dissociation from the heat shock proteins and subsequent translocation to the nucleus is 
triggered by ligand binding, but also by phosphorylation (Lalevee et al, 2010). The 
androgen receptor is phosphorylated in several residues (reviewed in (Itkonen & Mills, 
2011; Kuiper & Brinkmann, 1995)). The binding of a ligand has also been shown to 
change the phosphorylation pattern of the AR (Wong et al, 2004). 
 
 
1.4.2 Androgen receptor and prostate cancer 
Prostate cancer is the most common form of cancer in Sweden (Cancerfonden) and the 
second leading cause of male cancer deaths in many Western countries (Cancer.org; 
Prostate.org.au). Since abnormal AR signalling is a driving force behind the 
development of prostate cancer the treatment often involves androgen deprivation 
therapy. The first line of treatment often involves ligand deprivation, while treatment of 
metastatic prostate cancer involves the use of AR antagonists ((Huggins & Hodges, 
1972) reviewed in (Balk & Knudsen, 2008; Barmoshe & Zlotta, 2006; Heinlein & 
Chang, 2004)). In most patients androgen deprivation therapy is a very effective and 
well-tolerated method, however the challenge is that the disease will resurface after 18-
24 months leading to the development of castration-resistant prostate cancer (CRPC). 
The development of CRPC coincides with the increased levels of AR in the cells, and a 
study using prostate cancer xenograft models showed that this increase in AR mRNA 
production and AR protein level was both necessary and sufficient to convert prostate 
cancer to CRPC (Chen et al, 2004). The antiandrogens that are available today for 
treatment of metastatic prostate cancer, such as Bicalutamide (BIC), have a mixed 
agonist/antagonist activity in certain cellular context (reviewed in (Barmoshe & Zlotta, 
2006) and, thus, are not effective against CRPC. The recent development of AR ligands 
with a more clear-cut antiandrogenic activity may improve the prospects of anti-AR 
therapy in CRPC. 
 
 
1.5 CHROMATIN PRESETTING 
 
As was discussed earlier higher eukaryotes such as humans constitute some 200 
different cell types and each cell type is defined by its specific combination of 
expressed genes. The expression patterns for the different cell types are established by a 
cell-type specific combination of different transcription factors that bind the enhancer 
DNA and activate transcription. 
Genome wide studies have made it clear that the HREs are generally a part of a 
composite element, comprised of multiple factor binding sites (So et al, 2007). Thus, 
the promoters/enhancers containing HREs are not only bound by hormone receptors, 
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but also by different regulatory factors. The components of these composite elements 
tend to be strongly conserved for the same or similar cell type in different species (So et 
al, 2007). 
The same steroid receptor regulates a different set of genes in different cell types. But 
how is this different transcriptional response achieved? The answer is that the different 
combinations of transcription factors available in different cell types are responsible for 
orchestrating the cell-type specific binding of a steroid receptor. Genome wide studies 
of the chromatin structure in different cell types have revealed that DNase 
hypersensitive sites (DHS) in the vicinity of steroid receptor binding sites often are 
established before hormone activation (John et al, 2011). This is due to the binding of 
other transcription factors to the composite enhancer elements that remodels the 
chromatin to a more open configuration. In this way the binding of a hormone receptor, 
or basically any other signalling protein, to a certain enhancer is facilitated. For 
example, members of the C/EBP transcription factor family were shown to bind to and 
remodel the chromatin for PPARγ-binding during adipogenesis (Siersbaek et al, 2011). 
In the case of TGF-β signalling Smad3 has been shown to bind together with Oct4 in 
embryonic stem cells and Myod1 in myotubes, and hence activate a different set of 
genes in the different cell types (Mullen et al, 2011) 
Thus, the fact that the same steroid receptor can regulate a distinct set of genes in 
different cell types can be explained by the binding of different sets of cell-specific 
transcription factors. They act as pioneer factors interacting with chromatin in vicinity 
of HREs before receptor binding and, thus, programming, or preparing, the chromatin 
for further binding of steroid receptors. We refer to this process as chromatin presetting 
 In our system, the MMTV enhancer, we have shown that chromatin presetting can be 
achieved by various transcription factors (Astrand et al, 2009; Belikov et al, 2004). This 
will be discussed in detail below. 
 
 
1.6 FOXA1 
One example of a transcription factor that has been found to be a critical mediator of 
nuclear receptor signalling is the forkhead box protein A1, FoxA1(Belikov et al, 2009; 
Lupien et al, 2008). In vitro chromatin studies indicated that FoxA1 can stably bind 
within nucleosomes (Cirillo et al, 2002). FoxaA1 belongs to a large family of forkhead 
transcription factors, with over 40 members in mammals. FoxA1 has been shown to 
play a vital role in development of pancreas and lung, in kidney function as well as in 
metabolism and glucose homeostasis (reviewed in (Friedman & Kaestner, 2006)). 
FoxA1 is expressed during prostate development and it regulates a number of prostate 
specific genes (Friedman & Kaestner, 2006; Gao et al, 2003). A genome wide study 
showed that FoxA1 binding sites often located near the AR binding sites (Wang et al, 
2007) and FoxA1 has been shown to mediate both androgen, estrogen as well as 
glucocortiocid receptor signalling by presetting of the chromatin structure (reviewed in 
(Augello et al, 2011)). For example, FoxA1 has been shown to promote the expression 
of AR target genes in prostate development and estrogen target genes in ductal 
morphogenesis (reviewed in (Augello et al, 2011)). 
Overexpression of FoxA1 is a good prognostic marker for breast cancer (Wolf et al, 
2007), however, it is a bad prognostic factor for prostate cancer (Gerhardt et al, 2012). 
Overexpression of FoxA1 was observed 19% of primary and 89% of metastatic tumors 
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and FoxA1 expression positively correlates with tumor size (Jain et al, 2011). 
Furthermore, knock down of FoxA1 leads to a reduction of cell proliferation and 
inhibition of cell migration (Gerhardt et al, 2012). 
 
As mentioned above, the treatment of advanced metatastatic prostate cancer includes 
the use of AR antagonists that block the activity of the androgen receptor. 
Unfortunately, despite initially good response prostate cancer patients develop 
resistance to antiandrogen treatment and develop CRPC (Chen et al, 2004).  
Earlier in our lab it was shown that presetting of chromatin structure by FoxA1 can 
convert the glucocortiocoid receptor, GR, antagonist RU486 into a partial agonist 
(Belikov et al, 2009). Since FoxA1 is a bad prognostic marker for prostate cancer and 
since AR antagonists are not working after a certain time of treatment one may ask: Are 
these two phenomena related? Could the overexpression of FoxA1 in prostate cancer 
cells have the same effect on AR antagonists as on RU486?  
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2 EXPERIMENTAL SYSTEM 
 
2.1  XENOPUS OOCYTE SYSTEM 
 
In this thesis the Xenopus oocyte has been used as a model system, or rather an in vivo 
test tube, to study chromatin structure and DNA-protein interactions involved in gene 
regulation. The oocyte is a giant cell with high capacity to translate introduced mRNA 
into protein and to assemble injected DNA into chromatin, and has been used since late 
1950 to study a variety of cellular processes (reviewed in (Brown, 2004)). The idea 
behind our experiments is to reconstitute a hormone dependent signal transduction 
event via expression of protein(s) of interest in the oocyte by cytosolic injection of the 
corresponding mRNA(s) and intranuclear injection of reporter DNA, and thereafter 
study how the different transcription factors affect gene regulation and chromatin 
structure. 
 
 
2.1.1  Inside the oocyte 
 
Figure 6 Schematic drawing of a Xenopus oocytes, and injection of mRNA and ssDNA 
respectively (Courtesy of Dr. C. Åstrand) 
 
The stage VI Xenopus oocyte has a diameter of 1,3 mm. This can be compared to the 
size of a human egg that is 100 µm in diameter. The total volume of the Xenopus 
oocyte is about 1 µl. A schematic drawing of this oocyte, and of oocyte injection is 
presented in Fig. 6. The lower, white part (lighter gray in the picture) of the oocyte is 
called the vegetal pool, and in a fertilized egg the cells stemming from that part will 
form the inner tissues such as the gut. The brown pool (darker grey in the figure) is 
called the animal pool and gives rise to the outer tissues. The remarkably large nucleus 
of the oocyte, also called the germinal vesicle, is located inside of the animal pool. The 
diameter of the nucleus is one third of that of the oocyte, i.e roughly 0.4 mm. For 
comparison: the nucleus of a somatic cell has a diameter of 6 µm. The Xenopus oocyte 
harbors 12 pg of chromosomal DNA and 4000 pg of mitochondrial DNA (Hausen & 
Riebesell, 1991). 
During the maturation of the oocyte the cell accumulates a huge amount of histones and 
other proteins including basal transcription factors and other components of 
transcriptional/remodelling machinery as well as tRNAs and rRNA in the cell 
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(Adamson & Woodland, 1974). This forms a reserve for later development; the oocyte 
contains enough material to support the somatic cell division up to mid-blastula 
transition, equal to about 12 cell divisions. This means that the Xenopus oocyte has 
exceptionally high capacity of translating mRNA introduced in the oocyte into protein. 
The total mass of histone proteins in the stage VI is 140 ng (Hausen & Riebesell, 1991) 
indicating that the oocyte contains a huge excess of histones compared to chromosomal 
DNA. These core histones are often coupled to chaperones, including nucleoplasmin 
for later deposition on chromatin (Kleinschmidt et al, 1990). An analysis of the core 
histone content in the oocyte has been carried out showing that except for the canonical 
core histones the Xenopus oocytes contain a high amount of an embryo specific form of 
H2A.X (Shechter et al, 2009a; Shechter et al, 2009b). It should be noted that the 
sequence conservation between the human core histones and the Xenopus core histones 
is very high; they differ at only a few amino acids residues. 
Collectively, this means that the Xenopus oocyte is a useful model system for studying 
different aspects of chromatin structure, especially for linker histone studies, since they 
lack somatic H1 (Hock et al, 1993). This makes it possible to introduce different H1 
subtypes one by one in the cell, and study their effect on chromatin structure and 
transcription in a living system. 
 
 
2.1.2 Experimental setup 
The schedule for a typical experiment is shown in Fig. 7. The oocytes are injected in 
the cytoplasm with mRNA(s) coding for a protein(s) of interest. The exact amount of 
mRNA can vary, but is usually between 0.5-5 ng in an injection volume of 23 nl. After 
3-6 h incubation reporter ssDNA is injected into the nucleus. In the studies of H1 effect 
on chromatin ssM13 filamentous phage DNA was used as template. After injection 
ssDNA rapidly undergoes second strand synthesis concomitantly with chromatin 
assembly. 
 
 
Figure 7 Experimental setup The oocyte are isolated from the ovaries of the frog and treated 
with enzyme, liberase, to remove follicular cell layers from the oocytes. The next day mRNA is 
injected in the morning and ssDNA in the afternoon. One the second day the analysis, MNAse 
digestion, DMS treatment, determination of protein expression, or other kinds of analysis, is 
performed. 
 
Typically 3-7 ng of ssDNA is injected in a volume of 18 nl. The recovery rate is around 
90%, meaning that, for example, injection of 5 ng of ssDNA results in formation of 9 
ng of dsDNA. Thus the injected reporter DNA is the dominant one in the nucleus as 
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compared to the 12 pg of frog DNA. Detection of the chromatin pattern can be made in 
either by indirect means, such as Southern blotting or directly by the co-injection of α-
dCTP33 that upon incorporation into the DNA during second strand synthesis 
uniformely label the DNA. 
 
The level of protein expression is monitored either by Western blot or by incorporation 
of 14C-lysine during protein synthesis. In the latter case, the proteins are separated with 
SDS-PAGE and dried gels exposed to a phosphorimager screen. The relative intensity 
of the bands is then determined with the Image Gauge V4.1 Software.  
 
 
2.2 MICROCOCCAL NUCLEASE DIGESTION AND DETERMINATION OF 
NRL 
 
In Paper I we studied the effect of different H1 subtypes on the chromatin structure, 
using their effect on nucleosome repeat length, NRL, as a readout (Fig. 8). The NRL is 
determined by measuring the length of DNA that is protected from digestion with 
micrococcal nuclease, MNase that cleaves the linker DNA between the nucleosomes. 
Digestion of chromatin with MNase results in a characteristic cleavage pattern, known 
as nucleosomal ladder. As was discussed above the binding of H1 to chromatin induces 
an increase in the NRL. This in turns increases the length of the DNA protected from 
MNase digestion, and thus decreases the electrophoretic mobility of the corresponding 
DNA fragments on an agarose gel. This can be seen as an upward shift in the 
nucleosome ladder (see Fig 8B).  
To detect the MNase digestion pattern the single stranded DNA was co-injected with α-
dCTP33 and the DNA fragments resulting from MNase digestion of chromatin were 
separated on an agarose gel. The dried gel was analyzed using Fuji Bio-Imaging FLA-
7000 analyzer and the Image Gauge V4.1 Software. To determine the NRL the pattern 
of each lane was digitalized and presented as a profile. The upwards shift in the 
nucleosome ladder induced by the H1 protection of the linker DNA can be seen as shift 
in the location of the peaks corresponding to the polynucleosomes (Fig. 8C). By 
determining how the maximum of each peak is related to the known DNA marker the 
NRL can be determined. 
 
However, objective determination of the location of each maximum could be a 
problem. In addition, we sometimes dealt with very small differences. Therefore I 
developed a method where one makes use of a computer based curve-fitting algorithm 
in the program PeakFit® (Seasolve Software) that smoothens each peak and assigns it a 
value based on its electrophoretic mobility. This was done both for the profiles of the 
DNA markers and the profiles of the MNase digestion patterns. The known marker 
DNA lengths were then plotted as a function of their electrophoretic mobility. By 
inserting the value obtained for the threenucleosomal band into thus obtained equation 
for the closest ladder, the size of that band could be determined and, hence, the NRL 
calculated. 
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Figure 8 Determination of H1 induced increase in NRL (A) The nucleosome repeat length 
(B) The MNase digestion pattern in the absence and presence of H1 (C) Profile of lanes 1 and 4 
in Fig 8B 
 
The profiles of the MNase patterns were smoothened using the Loess algorithm while 
the DNA markers were smoothened using FFT filtering. Different algorithms were 
used for the profiles of the MNase pattern and for the peaks of the ladder since the FFT 
filtering algorithm is more suitable for sharp peaks. 
Another possible difficulty when determining NRL is bending of or “smiling” of the 
gel that results in shifting of the MNase pattern in relation to the ladder. When 
performing MNase digestion the oocyte homogenate was split in three equal portions 
that were digested individually. In this way we ended up with three independently 
analyzed samples from each H1 mRNA concentration that was used. To further 
minimize the influence of the bending of the gel the triplicates were loaded next to each 
other on the gel, in between two ladders so that each lane could be compared to the 
marker loaded in the next or second next lane. The NRL in the two lanes at the edges 
were determined using the equations of the marker next to it. The NRL of the lane in 
the middle was calculated with the equations of the markers on either side, and then a 
mean value was used.  
It should also be noted that due to technical problems occurring during gel drying the 
peaks are not totally smooth and this unevenness may play a role in where the program 
places the maximum. To minimize these problems gels were dried on positively 
charged membranes, to make sure that the DNA was not sucked through the nylon 
support during the drying process. As described above, each group was run in 
triplicates. If the pattern was very uneven, and the peak(s) clearly misplaced the sample 
was disregarded. 
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2.3 THE MMTV ENHANCER 
 
As a model system for chromatin studies we have utilized reporter DNA containing the 
long terminal repeat, LTR, of the mouse mammary tumor virus, MMTV fused to the 
herpes simplex virus thymidine kinase gene and cloned in an M13 vector (Belikov et al, 
2000). The mouse MMTV is a retrovirus that causes tumors in the mammary tissue of 
mice. It is activated by pregnancy hormones and transmitted through the milk of the 
infected mothers to their offspring (reviewed in (Gunzburg & Salmons, 1992)). The 1.2 
kb MMTV LTR harbors four steroid hormone binding elements (Figure 9) and it is one 
of the most widely used model system for glucocorticoid regulation (Gunzburg & 
Salmons, 1992; Ringold, 1979) but it can also be activated by progestines and 
androgens via binding of progesterone and androgen receptor, respectively. In addition 
to the steroid hormone receptors response elements, the MMTV LTR also harbors 
binding sites for nuclear factor 1 (NF1) (Nowock et al, 1985) and octamer binding 
factor 1 (Oct1) (Bruggemeier et al, 1991). Furthermore, binding sites for the forkhead 
transcription factor FoxA1 were found at -225 (single site) and at -51/-39 (double site) 
as well as -360/-332 (double site) relative the transcription start site (Belikov et al, 
2009). 
 
 
 
Figure 9 The MMTV reporter construct with indicated transcription factor binding sites 
 
In tissue culture cells, the MMTV LTR is organized on six nucleosomes, A-F, where 
the transcription start site is located at nucleosome A and the steroid response elements 
are located at nucleosome B. Hormone induced transcriptional activation does not 
cause any major changes to the nucleosome positioning, however the region 
corresponding to the B nucleosome, -60 to -250, becomes hypersensitive to DNaseI due 
to chromatin remodeling induced by the binding of steroid hormone receptors (Fragoso 
et al, 1995; Richard-Foy & Hager, 1987).  
 
 
2.3.1 MMTV enhancer studies in Xenopus oocytes 
In contrast to the translational positioning of the nucleosomes in the MMTV LTR in 
tissue culture cells, no preferred nucleosomal positioning along the DNA is observed in 
the inactive MMTV promoter upon reconstitution in Xenopus oocytes (Belikov et al, 
2000). However, hormone induction results in nucleosome arrangement similar to that 
in tissue culture cells, i.e a distinct translational positioning of six nucleosomes 
covering the MMTV LTR (Belikov et al, 2000). This rearrangement of nucleosomes is 
independent of transcriptional activity, since it occurs also when transcription is 
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inhibited; the presence of one high affinity steroid hormone response element is 
sufficient for induction of nucleosome positioning after addition of hormone in the 
presence of glucocorticoid receptor, GR (Belikov et al, 2000).  This nucleosome 
positioning is reversible since addition of glucocorticoid antagonists results in 
transcription secession and reverts it to the random arrangement of nucleosomes as 
observed in the absence of hormone (Belikov et al, 2001). Addition of NF1 and Oct1 
preset the MMTV chromatin in Xenopus oocytes for hormone induction; i.e arrange 
nucleosomes in a positioning intermediate between the non-induced state and the 
transcriptional arrangement, which leads to a faster binding of hormone receptors and a 
stronger hormone response (Belikov et al, 2004). Also FoxA1 has the capacity to open 
the chromatin structure for a more active response of the GR and enhanced hormone 
induced transcription (Belikov et al, 2009; Belikov et al, 2012). 
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3 RESULTS AND DISCUSSION 
3.1  PAPER I 
One unsolved question regarding the role of H1 is whether its presence in several 
similar variants in higher metazoans has a functional role. The Xenopus oocyte has no 
somatic linker histones but do contain an oocyte-specific maternal linker histone, B4, 
which, however, does not compete with somatic H1 for chromatin binding (Belikov et 
al, 2007). The lack of somatic types of H1 in the Xenopus oocyte thus offered the 
possibility to introduce and study H1 variants in the living cell individually. As readout 
for changes in chromatin we used the H1 induced increase in NRL. While the positive 
correlation between high H1 content and longer NRL is well established (Woodcock et 
al, 2006) , the effect of individual subtypes is not previously known. We focused on 
comparing the human ubiquitously expressed somatic subtypes, H1.2-H1.5 as well as 
the Xenopus somatic subtype H1A, the Xenopus differentiation specific subtype H10 
and the chicken differentiation specific subtype chH5.  
 
We decided to use the human hH1.4 subtype as a reference, and thus studied how 
different subtypes behave in comparison to hH1.4. Expression of increasing amounts of 
hH1.4 by cytoplasmic injection of hH1.4 mRNA results in a gradual increase in the 
NRL (Fig 8B and 8C). The increase in NRL reaches a plateau corresponding to ~1 H1 
bound per nucleosome (Belikov et al, 2007) thus arguing for that H1 binding is a 
saturable and, hence, specific. 
 
We started by comparing hH1.4 to the linker histones that differed from hH1.4 in terms 
of origin and/or expression pattern. Surprisingly no significant differences were 
observed between chH5, xH10, xH1A and hH1.4 in terms on their effect on NRL, 
however, we note that xH1A displays a lower affinity for chromatin binding. When 
comparing hH1.4 to hH1.2 or hH1.3 we saw significant differences in the effect on 
chromatin structure: hH1.4 typically results in an increase of 16.5± 3.5 bp, while both 
hH1.2 and hH1.3 give rise to an increase of roughly 6 bp (See summary in Fig 10). 
 
A comparison of hH1.4 and hH1.5 revealed that at the same level of expressed protein, 
hH1.4 elicits a much stronger effect on the NRL in comparison to hH1.5 and not even 
when hH1.5 is vastly overexpressed in the oocyte does the saturation curve show any 
signs of approaching a plateau. Thus, H1.5 expressed in Xenopus oocytes is not able to 
bind specifically to the chromatin target.  
 
We conclude that the ubiquitously expressed somatic human H1 variants have distinct 
effects on chromatin structure in vivo as well as different affinities for chromatin 
binding. hH1.4 has the strongest effect on NRL and hH1.2 and hH1.3 have the weakest. 
hH1.5 does not appear to bind to a specific chromatin site, since saturation is not 
reached, and has the lowest affinity for chromatin binding. These results argue for that 
the biggest differences neither take place between H1 subtypes from different species 
nor H1 subtypes differing in terms of expression pattern; on the contrary the biggest 
differences are found between the somatic human subtypes, the subtypes that in mice  
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Figure 10 Summary of result from Paper I. The increase in NRL induced by the presence of 
the different H1 subtypes 
 
have been shown to be able to replace each other to a certain extent and that are present 
in one and the same cell. Thus, our data supports the idea that different H1 subtypes 
play different roles in chromatin structure. 
 
In our hands hH1.4 resulted in the same increase in NRL as chH5, xH10, and xH1A -
H1 subtypes known to participate in formation of heterochromatic chromatin and gene 
silencing. xH1A is involved in the silencing of the 5S gene (Bouvet et al, 1994; 
Kandolf, 1994). chH5 is present in chicken erythrocyte which is a terminally 
differentiated cell with very compact and inert chromatin with long NRL. The chicken 
erythrocyte is indicated to have a total of 1.3 molecules of linker histones per 
nucleosome; 0.4 chH1 and 0.9 chH5 (Bates & Thomas, 1981; Morris, 1976). During 
the erythropoesis the NRL increases from 190 bp to 212 bp. This increase is correlated 
with the rising concentration of H5, but not H1, in these cells (Weintraub, 1978). 
During the maturation of Xenopus erythrocytes, the content of xH10, namely xH10-2 
the subtype used in the study, increases threefold (Koutzamani et al, 2002; Rutledge et 
al, 1984). This argues for that the xH10-2 function in Xenopus erythrocytes may be 
analogous to that of chH5 in chicken erythrocytes.  
 
Given the similarities in effect on chromatin structure between hH1.4 and chH5, xH10 
and xH1A we suggest that hH1.4 mainly participates in the formation and maintenance 
of heterochromatic structure and gene silencing. This would agree with a study by 
Th’ng et al. (Th'ng et al, 2005) who by using GFP-tagged H1 subtypes demonstrated 
that H1.4 is preferably localized in heterochromatic regions and H1.2 and H1.3 in 
euchromatic regions. The overexpression of mouse H10 and mouse H1.2 in cultured 
mouse fibroblasts showed that while both variants resulted in an increase in NRL the 
H10 overexpression resulted in significantly more dense chromatin resistant to MNase 
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digestion (Gunjan et al, 1999).This is in line with our data, that shows that H1.2 and 
H1.3 yielded a short increase in NRL.  Yet another study classified hH1.4 (as well as 
hH10) as a strong chromatin condenser, hH1.3 as an intermediate and hH1.2 (and 
hH1.1) as a weak condenser (Clausell et al, 2009) 
Thus our data are in agreement with the results from others and suggest a primary role 
in formation and/or maintenance of more dense and/or inactive chromatin structures for 
hH1.4 and a role in formation and/or maintenance of more active chromatin structures 
for hH1.2 and hH1.3. 
 
Regrettably we did not have enough time to elucidate the effects of the different H1 
subtypes on gene expression. We performed initial studies aiming at elucidation of the 
effect of hH1.4 and hH1.2 on transcription factor, GR, binding and the MMTV 
transcription. Both hH1.4 and hH1.2 were found to stimulate GR binding, however the 
effect of hH1.2 was more pronounced. hH1.2 also give slightly more stimulation on 
MMTV transcription level as compared to hH1.4. These differences were, however, not 
significant. 
 
Our results are in agreement with studies by others where the roles of H1 subtypes in 
functioning of eukaryotic genome have been elucidated. Overexpression of either 
murine H10 or murine H1.2 in 3T3 cells showed that H10 inhibited transcription of 
more genes than H1.2 (Bhan et al, 2008; Brown et al, 1996). When H10 and H1.2-H1.5 
were knocked down one by one in human breast cancer cell the ratio of down-to-
upregulated genes after knock down of hH1.2 was of 2.7, while the same ratio for 
knock down of hH1.4 and hH1.5 was 1.4 and 1 respectively. This strengthens the 
notion of hH1.4 and hH1.5 having more repressive role compared to hH1.2. 
Interestingly, the ratio of down-to-up regulated genes in hH10 knock down cells was 
1.9, i.e. higher than for  hH1.4 and hH1.5 (Sancho et al, 2008). As described earlier 
knock down of either H1.2, H1.3 or H1.4 had no visible effect on the phenotype of the 
affected mice (Fan et al, 2001). A more detailed analysis revealed that deletion of H1.3 
and H1.4, or H1.4 in combination with H10 attenuated the age-dependent silencing of 
the human β-globin transgene, while the deletion of H1.2 or H10 alone did not affect 
the rate of silencing (Alami et al, 2003). ChIP based studies have shown that hH1.3 and 
hH1.4 are depleted from active chromatin, as opposed to hH1.5. The same study also 
showed that H1.2, unlike the other subtypes, remained present at the HSP90 promoter 
after heat shock induction (Parseghian et al, 2001; Parseghian et al, 2000). Hence, this 
study supports the notion of H1.4 as being a part of repressive chromatin structure and 
H1.2 to be enriched in active chromatin. It should be noted that the observed depletion 
of H1.3 from active chromatin and the presence of H1.5 in the same study disagree 
with results by others (Sancho et al, 2008) as well as our expectations based on its short 
increase in NRL. Here it should be pointed out that there have been major problems in 
the making of antibodies that are specific for a certain H1 subtype and hence, one 
cannot exclude that the data from this study might be compromised depending on the 
quality of the antibodies. 
 
Taken together, these results indicate that the chromatin structure induced by H1.2 
binding is more open and facilitates transcription while the chromatin structure formed 
by H1.4, H10 and H1.5 is more repressive. When it comes to H1.3 the results differ, 
and we suggest that this one might be more of an intermediate subtype. However, 
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neither of the H1 subtypes is fully either euchromatic or heterochromatic. For example, 
H1.2 and can also act as repressor of certain genes, as when it is part of the complex 
that represses p53 mediated transcription (as described above) (Kim et al, 2008). 
 
But what is the cause of the different effects on NRL and the different affinity for 
chromatin binding that we observe? Results from others have revealed that H1 binding 
for the most part is controlled through cooperation between the globular and C-terminal 
domains (Brown et al, 2006; Stasevich et al, 2010) while chromatin compaction 
abilities and affinity for chromatin binding are largely influenced by the C-terminus 
(Clausell et al, 2009; Th'ng et al, 2005). In Paper I, we do not find any correlation 
between effect on NRL and the factors that have been proposed to influence H1’s 
binding abilities i.e. C-terminal amino acid composition length, distribution of positive 
charge and number of phosphorylation motifs. The biggest differences are found 
between xH1A, xH10 and chH5 on one hand and the human somatic subtypes on the 
other. Data from others have suggested that different regions of the C-terminal domain 
contribute differently to H1’s binding affinity in vitro (Caterino et al, 2011) and that 
some parts are more crucial than others for H1’s ability to stabilize folded secondary 
chromatin structures (Lu & Hansen, 2004). Another study shows that amino acid 
composition in different parts of the H1 C-terminal domain rather than sequence 
determines H1’s binding abilities (Lu et al, 2009a). However, when aligning the C-
terminal domains of the different linker histone subtypes to that of hH1.4 and dividing 
each tail in four parts in order to compare the distribution of positively charged residues 
as well as phosphorylation motif distiribution between subtypes the biggest similarities 
were once again seen between the human subtypes, while chH5, xH10 and xH1A 
differed (Paper I, Supplements). In Paper I we thus conclude that other factors than 
amino acid composition of the C-terminal domain affects H1’s effect on NRL.  
 
 
3.2 PAPER II 
 
The N-terminus of H1 has received much less attention compared to the C-terminal 
domain. In Paper II we used the same experimental strategy as in Paper I to elucidate 
the behaviour of hH1.4 devoid of its N-terminal domain, ΔN-hH1.4, as compared to 
hH1.4 in its wild type form when it comes to effect on chromatin structure and its 
affinity for chromatin binding. We showed that wt hH1.4 and ΔN-hH1.4 results in the 
same final increase in NRL. However, 3-4 fold more ΔN-hH1.4 compared to wt hH1.4 
was needed to reach the same effect on NRL and at higher levels of ΔN-hH1.4 the 
nucleosome ladder pattern started to deteriorate and become smeary. This kind of 
pattern can otherwise be seen when H1 is vastly overexpressed in the oocyte, and starts 
to bind unspecifically (Belikov et al, 2007). In the case of ΔN-hH1.4 the smearing of 
the pattern was present already at the point where saturation of the DNA was reached. 
At the same amount of wt hH1.4 no deterioration in the nucleosome ladder was 
observed. When doubling the amount of ΔN-hH1.4 the smearing of the pattern was 
even more pronounced. The lack of N-terminus seems to impair the ability of hH1.4 to 
bind specifically to chromatin, as reflected by the progressive deterioration of the 
pattern. Thus, a larger fraction of ΔN-hH1.4 takes part in unspecific chromatin 
interactions and it is not surprising that more protein is needed to reach saturation as 
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compared to the wild type hH1.4. Our results imply that the N-terminal domain is an 
important determinant of affinity and specificity of H1-chromatin interactions. 
 
However, since the absence of a N-terminal domain did not affect H1.4’s effect on 
increase in NRL it seems unlikely that differences in the N-terminal domains are 
directly responsible for the different effect on NRL we observed in Paper I.  
 
So what is then the explanation for the differences observed? The N-terminal domain 
together with the globular domain have been shown to be responsible for correct 
localization pattern of the oocyte specific H1 subtype H1FOO (Becker et al, 2005) and 
domain swapping revealed that the individual effects on transcription of H10 and H1.2 
upon overexpression in 3T3 cells (Brown et al, 1996) followed the globular domain 
(Brown et al, 1997). By the use of point mutations in the globular domain and FRAP 
the binding domain of H1.2 was shown to be distinct from that of H10 (George et al, 
2010). This would lead to different binding geometry of these subtypes, and this would 
most probably lead to different kinds of chromatin structure. At a first glance the 
differences in globular domains does not provide the explanation for the differences 
observed between the human subtypes in Paper I since the globular domain of hH1.2 
and hH1.3 are identical to that of hH1.4 (Fig 4). However, if one is allowed to 
speculate; the fact that the amino acid sequences of the globular domains of these linker 
histones are identical does not necessarily mean that they bind DNA in the same way. 
In this respect one should not disregard the potential impact of the C-and the N-
terminal domains and their influence on the geometry of H1 binding. A recent Paper by 
Vyas and Brown indicates that swapping the C-terminal domains of H1.2 and H10 also 
resulted in the corresponding change in chromatin interaction surface (Vyas & Brown, 
2012). This result indicates that the C-terminal domain is responsible for the correct 
placement of these H1 subtypes. The different effects of H1 subtypes may thus be 
explained by a combined effect of the globular and C-terminal domain. In the study by 
Vyas and Brown, swapping the N-terminal domain of H1.2 for that of H10 did not 
change the interaction surfaces of the globular domain, however, switching the N-
terminal domain of H10 to that of H1.2 did slightly impair the binding mode of H10, 
although not to the same extent as when the C-terminal domains were exchanged. Thus 
it seems like the N-terminal domain is of slightly more importance for the binding of 
H10 than for H1.2. The result from this study indicates that the N-terminal domain is of 
more importance for some subtypes than others. When the C-terminal domains of H1.5 
and H1.4 were exchanged for that of H1.1 the resulting chimera protein behaved almost 
identical to H1.1 but when the C-terminal domain of H1.1 was swapped to that of H1.4 
or H1.5 the chimera protein displayed recovery rate after photobleaching that was an 
intermediate of H1.1 and H1.4/H1.5 (Th'ng et al, 2005). The binding affinity thus 
follows the C-terminal domain in some cases but not in others, lending further proof to 
the concept of the domains having different roles in different subtypes. 
We conclude that the answer to the question of what decides H1’s binding abilities 
cannot be found solely in the sequence of the N-terminal, the C-terminal or the globular 
domain, but most probably involves a combination of all these domains. We also 
propose that the exact contribution of each domain may differ between subtypes. 
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3.3  PAPER III 
 
As described previously, many antiandrogens that are available today for treatment of 
prostate cancer, such as bicalutamide (BIC), have mixed agonist/antagonist activity in 
certain cellular context. The recent development of AR ligands with a more clear-cut 
antiandrogenic activity may improve the prospects of such therapy. MDV3100 (MDV) 
or Enzalutamide is an AR antagonist developed by Medivation for the treatment of 
CRPC and is currently in Phase 3 clinical trials. Since high levels of transcription factor 
FoxA1 is a negative prognostic factor in prostate cancer and FoxA1 was previously 
shown to convert the glucocorticoid antagonist RU486 to a partial agonist we found it 
of interest to investigate the possible effect of FoxA1 on the transcriptional outcome of 
AR antagonists. 
 
To address the effect of FoxA1 on AR action oocytes were injected with AR mRNA 
only or with a combination of AR and FoxA1 mRNA and placed in media containing 
agonist R1881 or either of the antagonists: BIC or MDV. As control we used oocytes 
injected with DNA only since a drawback of the Xenopus oocyte system in these 
studies is that the oocytes contain significant amounts of endogenous androgens. 
Nuclear translocation induced by either of the ligands was studied by analysis of the 
protein content of manually isolated nuclear and cytoplasm by Western blotting. We 
were able to show that both antagonists, upon binding to AR, can translocate the AR-
ligand complex to the nucleus, albeit with reduced efficiency for MDV.  
While in the nucleus both AR-antagonist complexes have the potential to bind 
sequence specifically to the HRE. The DNA binding is strongly enhanced by co-
expression of FoxA1 that presets the enhancer chromatin and, hence, makes the HRE 
more accessible for AR binding. In this context the AR-BIC complex antagonistic 
activity is considerably compromised as demonstrated by a significant chromatin 
remodeling and induction of a robust MMTV transcription whereas AR-MDV shows a 
more persistent antagonistic activity. Since the Xenopus oocyte contains endogenous 
androgens we are unable to separate the loss of inhibition from the intrinsic agonistic 
activity that may be exerted by the AR-BIC complex in the FoxA1 context. On the 
other hand the endogenous androgens present in oocytes may mimic a clinical situation 
since the tumor tissue may produce androgenic ligands and where high levels of FoxA1 
expressed in the cancer cells might compromise the therapeutic effect of BIC. This 
motivates the search for compounds with a more persistent antiandrogenic activity. 
 
In conclusion our work provides a mechanistic explanation of how prostate cancer cells 
may become insensitive to BIC and sheds light on how AR-antagonist complex 
function in the context of FoxA1.  
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4 PRELIMINARY RESULTS 
 
One factor that makes the study of the linker histone subtypes problematic is 
difficulties is raising specific antibodies against different H1 subtypes. Thus many 
studies on the linker histones have been performed with GFP-tagged H1, for example 
when studying intracellular localization of different subtypes or H1 chromatin binding 
properties by FRAP (Hendzel et al, 2004; Lever et al, 2000; Misteli et al, 2000). 
However, the addition of the GFP-protein, i.e. 238 extra amino acids, to the 200 aa H1 
protein has the potential to affect its properties, such as affinity for chromatin binding 
and its effect on chromatin structure. A study by Hendzel et al showed that H1.1 had 
much lower affinity for chromatin binding when the GFP tag was placed in the C-
terminal domain as compared to when it was placed in the N-terminus. In fact, the 
presence of a GFP-tag in the C-terminal domain had almost the same effect as deleting 
the whole N-terminus (Hendzel et al, 2004). However, no study has been made where 
GFP-tagged H1 has been compared to untagged H1. Thus one cannot exclude that the 
GFP tag also affects the properties of H1 when placed in the N-terminus.  
 
Using the same experimental setup as described in Paper I and Paper II we have 
compared the wild type hH1.4 to hH1.4 tagged with GFP in either N-or C-terminal 
domain. Our preliminary results indicate that when placed in the N-terminal domain the 
GFP-tag has no influence on hH1.4’s affinity for chromatin binding or effect on NRL. 
However, when fused to the C-terminus, the GFP tag significantly compromises H1 
affinity for chromatin binding, but again has no effect on the increase in NRL. 
 
We are planning to continue these studies by addressing how the GFP-tag affects 
hH1.4’s mobility in the oocyte nucleus by the use of FRAP to be able to compare the 
two methods. 
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5 CONCLUSIONS 
In this thesis I have shown that: 
 
 (I) Ubiquitously expressed H1 subtypes differ in their effect on chromatin structure. 
This strengthens the idea of H1 subtypes having individual roles in chromatin 
organization and that the presence of a certain subtype on the chromatin fiber may 
contribute to the formation of a distinct type of chromatin structure.   
 
We suggest that hH1.4, which results in an increase in NRL comparable to those of 
subtypes found in repressed chromatin in specialized cells, may contribute to the 
formation and/or maintenance of repressed chromatin. hH1.2 and hH1.3 both result in 
about half of the effect on NRL as compared to hH1.4 and in agreement with data from 
others (Alami et al, 2003; Clausell et al, 2009) we propose an euchromatic role for 
hH1.2 and an intermediate role for hH1.3.  
 
(II) The N-terminal domain was shown to support H1’s ability to bind specifically to 
chromatin, but it had no effect on NRL. We suggest that the N-terminus is involved in 
the correct positioning of H1 along the chromatin fiber. 
 
(III) The chromatin presetting by transcription factor FoxA1 heavily compromises the 
antagonist properties of the first-generation androgen receptor antagonist BIC and to 
some extent also of the second-generation antagonist MDV. 
 
We showed that the AR-MDV complex is translocated to the cell nucleus, albeit to a 
lesser extent than the AR-BIC complex. While in the nucleus, both complexes have the 
same ability to bind specifically to the HREs. Upon DNA binding agonist-AR complex 
recruit co-activators needed for chromatin remodeling. This ability is only slightly 
compromised for BIC-AR complex in the presence of FoxA1 while in the same context 
AR-MDV fails to recruit coactivators and other components of chromatin remodeling 
machinery. Since high levels of FoxA1 have been shown to be a bad prognostic factor 
for prostate tumors (Gerhardt et al, 2012; Jain et al, 2011) these findings may be of 
clinical relevance. 
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